Genetic factors, particularly variations in the leptin receptor (LepR) gene, significantly influence insulin sensitivity and lipid metabolism, contributing to MASLD susceptibility and progression [8]. The gene discussed is LEPR; the disease is metabolic dysfunction-associated steatotic liver disease.